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Abstract: Belgium is among the European countries that are the most affected by allergic rhinitis. Pollen grains
and fungal spores represent important triggers of symptoms. However, few studies have investigated their real
link with disease morbidity over several years. Based on aeroallergen counts and health insurance datasets, the
relationship between daily changes in pollen, fungal spore concentrations and daily changes in reimbursable
systemic antihistamine sales has been investigated between 2005 and 2011 in the Brussels-Capital Region. A
Generalized Linear Model was used and adjusted for air pollution, meteorological conditions, flu, seasonal
component and day of the week. We observed an augmentation in drug sales despite no significant increase in
allergen levels in the long term. The relative risk of buying allergy medications associated with an interquartile
augmentation in pollen distributions increased significantly for Poaceae, Betula, Carpinus, Fraxinus and
Quercus. Poaceae affected the widest age group and led to the highest increase of risk which reached 1.13 (95%
CI [1.11–1.14]) among the 19- to 39-year-old men. Betula showed the second most consistent relationship
across age groups. Clear identification of the provoking agents may improve disease management by cus-
tomizing prevention programmes. This work also opens several research perspectives related to impact of
climate modification or subpopulation sensitivity.
Keywords: allergic rhinitis, ecology, fungal spore, medication, pollen, public health
INTRODUCTION
Allergic rhinitis is a chronic inflammatory disease of the
upper airways caused by an IgE-mediated reaction.
Through many nose and throat symptoms such as sneezing,
itchiness, nasal congestion or discharge, it significantly
impairs patients’ quality of life (Bousquet et al. 2008).
According to the World Allergy Organization, it touched
between 10 and 30% of the world population in 2011
(Pawankar et al. 2011). Belgium seems particularly affected.
In a cross-sectional study carried out by Bauchau and
Durham in six European countries in 2001, this country
showed the highest prevalence: 28,5% (Bauchau and Dur-
ham 2004).
Symptoms can be triggered by indoor allergens
including pets’ dander, house dust mite and/or outdoor
Ariane Guilbert and Koen Simons contributed equally to this work.
Published online: May 12, 2016
Correspondence to: Ariane Guilbert, e-mail: ariane.guilbert@wiv-isp.be
EcoHealth 13, 303–315, 2016
DOI: 10.1007/s10393-016-1124-x
Original Contribution
 2016 The Author(s)
allergens such as pollen grains and fungal spores. These last
two categories are responsible for the seasonal symptom
expression commonly observed (Pedersen and Weeke 1984;
Bousquet et al. 2008). Air pollution plays also a key role,
tending to worsen allergic rhinitis symptoms (Hajat et al.
2001). More generally, global environmental change such as
increase in temperature and CO2 concentration, new ter-
ritory planning strategies, introduction of new species, are
likely to affect patients by modifying distribution, con-
centration, season, allergenicity of pollen grains but also
potentially mould spores (Beggs 2004; Reid and Gamble
2009).
Exploring provoking agents more closely may help to
improve disease management. However, few studies have
investigated this issue and the methodology was rather
diverse. While some analysed the association between
pollen levels and medication sales (Laaidi 2000; Christophe
et al. 2003; Ravault et al. 2005; Sa´nchez-Mesa et al. 2005;
Zeghnoun et al. 2005; Fuhrman et al. 2007; Johnston et al.
2009; Sheffield et al. 2011; Van Vliet and Tobi 2012;
Motreff et al. 2013; Caillaud et al. 2015) or medical visits
(Pedersen and Weeke 1984; Breton et al. 2006; Zhang et al.
2012), others looked at emergency, department visits
(Cakmak et al. 2002), focusing on the most severe cases.
Whereas some explored the relationship with time series
designs (Cakmak et al. 2002; Ravault et al. 2005; Zeghnoun
et al. 2005; Breton et al. 2006; Fuhrman et al. 2007; John-
ston et al. 2009; Sheffield et al. 2011; Van Vliet and Tobi
2012; Zhang et al. 2012; Motreff et al. 2013; Caillaud et al.
2015), others used descriptive or correlation methods
(Pedersen and Weeke 1984; Laaidi 2000; Christophe et al.
2003; Sa´nchez-Mesa et al. 2005), failing to adjust for con-
founders. In addition, local context including vegetation,
topography, physician prescription behaviour, etc. influ-
ences results and limits extrapolation to other regions.
Based on time series analysis and restricting to the Euro-
pean context, a few studies highlighted the relationship
between allergy medication sales and Alnus, Betula, Carpi-
nus, Corylus, Cupressaceae, Fraxinus, Poaceae (also referred
to as Gramineae), Olea, Plantaginaceae, Platanus, Quercus,
Salix, Urticaceae pollen levels (Ravault et al. 2005; Zegh-
noun et al. 2005; Fuhrman et al. 2007; Van Vliet and Tobi
2012; Motreff et al. 2013; Caillaud et al. 2015). However,
more than half of the studies concentrated on the same
geographical area and data collection methods did not
cover the whole studied population.
This study aimed to assess, for the first time in the
Brussels-Capital Region (BCR) and in Belgium, the short-
term relationship between pollen levels and allergy medi-
cation sales based on extensive administrative datasets. It
also investigated the role of outdoor fungal spores which
received little attention despite their high allergenic prop-
erties (Tariq et al. 1996; Andersson et al. 2003).
METHODS
Settings
The research has been carried out in the BCR. This urban
area is composed of 19 municipalities representing
approximately 1,175,000 inhabitants spread over 161 km2.
Allergen concentrations, air pollution, weather, health be-
haviours and medical practices were all deemed sufficiently
homogeneous over this sector. The studied time period
covers seven pollen seasons, from 2005 to 2011 included.
Exposure Measures
The analysis investigated the impact of nine pollen types
(Alnus, Betula, Carpinus, Corylus, Fraxinus, Poaceae, Quer-
cus, Taxus combined with Cupressaceae) and two fungal
spore types (Alternaria and Cladosporium). This selection
was based on the allergenicity and distribution of these
substances in the BCR. Their daily concentrations were
provided by the Mycology and Aerobiology service (www.
airallergy.be) of the Belgian Scientific Institute of Public
Health (WIV-ISP). The counts of pollen and fungal spores in
the air were obtained using a Burkard volumetric spore
sampler located on the top of the WIV-ISP building, in the
centre of the study area. Measurements were carried out
7 days a week, from January to November included. For the
month of December, zeros were imputed for all types. This
decision was based on experience: regular pollen counts have
shown that by the end of September, allergenic pollen con-
centrations become close to zero. A similar trend is observed
for fungal spores, whose concentrations drastically decrease
and become too low to trigger symptoms in November.
Outcome Measures
The health impact of pollen grains and fungal spores was
assessed based on their association with reimbursable
‘‘Antihistamines for systemic use’’ sales (R06A category
according to the World Health Organization Anatomical
Therapeutic Chemical classification system [ATC]; detailed
list available as supplemental material), referred to as ‘‘al-
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lergy medications’’ hereinafter. Figures were obtained from
the Pharmanet database, managed by the InterMutualistic
Agency. This administrative system records, on a daily
basis, data on any purchase of refundable drugs made by a
patient affiliated to the social security, in one of the public
Belgian pharmacies. It contains for each drug sale: infor-
mation on product code, quantity, day of purchase and
customer through an encoded social security number. This
identification number enabled merging of the Pharmanet
records with the Population database. The latter, also
managed by the InterMutualistic Agency, includes data on
customer sociodemographic characteristics (age, gender,
place of residence). Because health insurance is mandatory
in Belgium, these databases are virtually complete. For this
study, sales data were restricted to people residing in the
BCR at the time of purchase.
Confounding Factors
Among air pollutants, PM10, NO2, SO2 and O3 were con-
sidered as potential confounders. The Belgian Interregional
Communication Cell for the Environment provided daily
mean concentrations for the BCR. These data are derived
from a national monitoring network (11 stations in the
BCR), augmented by a land-use regression model: RIO-
CORINE (Janssen et al. 2008). The influence of meteoro-
logical factors including daily minimal temperature and
average relative humidity, was taken into account. Data
were measured and provided by the Royal Meteorological
Institute of Belgium located within the study area. Day of
the week, holiday and flu season (binary variable defined by
the WIV-ISP in partnership with a representative network
of sentinel general practitioners) were also introduced in
the statistical model as cofactors.
Statistical Analysis
Sales records were aggregated into ecological time series. A
Generalized Linear Model based on a Poisson distribution
with log-link and corrected for overdispersion was used
(McCullagh and Nelder 1989). Single pollen and spore
models were fit, using an unrestricted distributed lag of zero
to 10 days (Almon 1965). For each pollutant, a daily average
estimate over the study area was calculated (local concen-
trations weighted by the total population per cell). Because of
the high intercorrelation between these compounds, the
model was only corrected for same day PM10. Sensitivity
analyses showed similar results when correcting for same day
NO2, etc. Based on prior work and sensitivity analysis, cubic
splines with seven degrees of freedom per year were used to
adjust for season and trend. Daily minimum temperature
and daily average relative humidity were modelled with
natural cubic splines of, respectively six and three degrees of
freedom. Flu season was introduced as a binary variable per
season. Day of the week was also considered. Pharmacies are
all open on weekdays; however, in the weekend and on hol-
idays (official days off), access is diminished which results in
low or zero sale volumes. Thus, only weekdays provide
valuable information and other days were removed from the
outcome series. As pollen sensitivity and health behaviour
may vary according to age, analyses were performed for
different age groups (0–5, 6–12, 13–18, 19–39, 40–64, 65–84
and 85 years or more). Impact of gender was also considered.
All analysis were carried out using R 3.1.0 (R Core Team
2015). This study has been approved by the Belgian Com-
mission for the Protection of Privacy.
RESULTS
Pollen and Fungal Spore Exposure
Exposure period ranged from January to the beginning of
September for pollen grains and from April to November
for fungal spores. The distribution of allergen concentra-
tions varied greatly between types and from 1 year to an-
other for the same type (especially for Carpinus and
Fraxinus). Maximal concentrations fluctuated between 167
grains/m3 for Corylus and 43,230 spores/m3 for Cladospo-
rium. Results are summarized in Fig. 1 and Table 1.
Medication Sales
1,370,535 reimbursable allergy medication purchases by
347,034 distinct individuals were recorded between 2005
and 2011. Table 2 provides descriptive information on al-
lergy medication sales. The majority of patients (62.8%)
bought only one box of reimbursed allergy medications per
year, 78.9% bought two or less, 97.7% bought less than ten
boxes.
Table 3 shows the percentage of residents buying at
least one eligible product in a given year. For most age
groups, percentages increased (non-consistently) between
2005 and 2011. The 13–18 years and 40–64 years groups
showed the highest increase (up to 21% for men 40–
64 years old). In general, purchases were more frequent
among males at early age (0-12 years) while females were
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more likely to buy allergy medications from age 13. Male/
female prevalence ratio varied between 1.18 for 6–12 years
group and 0.58 for 40–64 years group.
Relationship Between Pollen, Fungal Spore Expo-
sure and Medication Sales
Figure 2 shows the temporal evolution of several pollen,
fungal spore concentrations and allergy medication sales.
For readability, only three aeroallergens (Alternaria, Betula
and Poaceae) and three age groups (19–39, 40–64 and 65–
84 years) are displayed based on their relevance. Overall,
medication sales exhibited a high seasonality with a note-
worthy peak between April and June. These variations
tended to be less and less pronounced with increasing age.
Men and women followed a similar pattern.
The short-term association between pollen, spore levels
and allergy medication sales has been investigated for a lag
zero to 10 days, adjusting for the various confounders.
Results are expressed as the relative risk of buying allergy
medications associated with an interquartile augmentation
(InterQuartile Range [IQR]) in pollen or spore distribu-
tions with zero to 10 days lag. They are summarized in
Table 4. Considering the overall population, risks were
significantly increased for Poaceae, Betula, Carpinus,
Fraxinus and Quercus. No significant association was ob-
served for Corylus, Alnus and Taxus Cupressaceae. Differ-
ences across age were manifest. From 0 to 5 years, the risk
only increased for Poaceae. From 6 to 12 years, the risk was
positive for Poaceae but also for Betula and Carpinus. From
13 to 18 years, Poaceae, Betula and Quercus were associated
with an increasing risk. From 19 to 64 years, the risk in-
Table 1. Descriptive Data on Pollen and Fungal Spore Levels, BCR, 2005–2011
Annual airborne pollen/spore counts Contribution* to annual air-
borne pollen load (%)
Maximum daily airborne
pollen/spore count
Min Median Max Min Median Max
Corylus 278 557 1743 1.43 2.19 6.05 167
Alnus 563 1804 2434 3.52 6.35 9.26 342
Taxus Cupressaceae 3465 5525 10,757 19.37 25.73 32.25 2595
Fraxinus 242 1419 3360 1.04 7.40 10.54 728
Carpinus 29 285 1001 0.18 1.00 4.98 387
Betula 3740 8240 12,141 25.34 35.30 44.92 2464
Quercus 760 2371 5335 3.90 10.95 18.53 560
Poaceae 1926 2589 3649 7.55 9.89 18.42 246
Alternaria 10,435 21,520 29,210 / / / 1985
Cladosporium 667,775 736,860 1,122,660 / / / 43,230
*Contribution calculated as ratio of type count over the sum of all pollen types listed in the table
Figure 1. Descriptive statistics on pollen, spore levels, BCR, 2005–2011. Colour intensity represents the probability of observing pollen or spore
counts larger than 1% of the type’s maximum concentration. The vertical line highlights the month from which pollen and spore counts are
considered equal to zero
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creased for Poaceae, Betula, Carpinus, Fraxinus and Quer-
cus. The latter specifically affected individuals aged from 65
to 84 years. No positive association was demonstrated for
the oldest group (85 years or more). When restricting to
pollen, the significant relative risks per IQR ranged from
1.02 (95% CI [1.01–1.03]) due to Fraxinus to 1.13 (95% CI
[1.11–1.14]) due to Poaceae. Gender impacted results with
no clear pattern according to allergen types. Associations
seemed a bit stronger for men than women among the 19–
64 years group. Regarding Alternaria and Cladosporium
spores, a significantly negative risk was observed for most
of the age and gender groups.
DISCUSSION
This time series analysis investigated the association be-
tween pollen and fungal spore counts and allergy medica-
Table 2. Distribution of Daily Number of Sales of Eligible Allergy Medication (Number of Boxes Per Day), BCR, 2005–2011
Age Gender Min Max Mean Median 1st quartile 3rd quartile
0-5 years Male 1 42 16.4 16 12 20
Female 1 39 12.8 12 9 16
6-12 years Male 2 68 21.2 20 15 26
Female 3 42 15.9 15 12 19
13-18 years Male 1 48 14.6 13 10 18
Female 1 48 14.3 13 10 17
19-39 years Male 20 218 58.9 50 41 68
Female 41 308 96.0 82 70 113
40-64 years Male 29 203 86.3 79 67 100
Female 68 396 165.0 148 131 189
65-84 years Male 23 105 54.5 54 46 62
Female 25 191 105.0 102 89 118
85 or more years Male 0 30 9.1 9 6 11
Female 12 103 32.2 31 26 36
Figures calculated excluding Saturday, Sunday and holidays
Table 3. Percentage of Inhabitants Buying at Least One Eligible Allergy Drug, BCR, 2005–2011
Age Gender 2005 2006 2007 2008 2009 2010 2011
0-5 years Male 8.95 8.47 8.13 7.86 7.16 6.87 7.22
Female 7.83 7.18 6.81 6.61 5.96 6.00 6.34
6-12 years Male 8.13 8.30 8.20 8.14 8.48 8.05 8.30
Female 6.97 6.94 6.92 7.03 7.10 6.90 6.80
13-18 years Male 6.25 6.63 7.07 7.33 7.57 7.00 7.21
Female 6.95 7.07 7.26 8.00 7.69 7.67 8.05
19-39 years Male 5.72 5.87 5.93 6.25 6.25 6.04 6.12
Female 9.08 9.31 9.52 9.87 9.76 9.59 9.66
40-64 years Male 6.94 7.22 7.24 8.23 8.36 8.40 8.38
Female 12.55 13.02 13.09 14.02 14.11 13.74 14.22
65-84 years Male 9.94 10.34 10.34 10.99 10.84 10.36 10.23
Female 13.06 13.18 13.30 13.73 13.73 13.46 13.50
85 or more years Male 10.46 10.20 10.16 10.51 10.62 10.84 11.02
Female 12.22 12.41 12.19 12.58 12.63 12.28 12.03
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tion sales at the BCR scale. Nine pollen (Alnus, Betula,
Carpinus, Corylus, Fraxinus, Poaceae, Quercus, Taxus
combined with Cupressaceae) and two spore (Alternaria,
Cladosporium) types were tested, taking into account the
confounding effect of air pollution, weather and flu.
Data on allergy medication sales were used to assess the
2011 prevalence of treated allergic rhinitis (percentage of
residents buying at least one eligible product in a given
year). This varied between 6.12% and 14.22% according to
age and gender group. These results are consistent with
Bauchau and Durham who estimated that 11.9% of the
Belgian population used medication for allergic rhinitis in
2001. These figures can be compared with the percentage of
individuals self-aware of their disease which reached 20.5%
and the percentage of clinically confirmable cases which
came to 28.5% (Bauchau and Durham 2004). Another
study estimated that 34.1% of the Belgian population is
sensitized to at least one common aeroallergen (Bousquet
et al. 2007). Despite some approximations related to our
methodology (described below), these results suggest a gap
between real disease prevalence and patient behaviour.
The prevalence of treated allergic rhinitis increased
between 2005 and 2011, especially among teenager and
middle age groups who showed a percentage increase up to
21% for men 40–64 years old (from 6.94% in 2005 to
8.38% in 2011). Overall, this rise was much lower than the
one observed in England between 2001 and 2005 which
reached 45,5% (Ghouri et al. 2008). Reasons for this in-
crease are likely to be multifactorial. They may reflect real
evolution of disease prevalence as well as change in medical
practice, practitioner or public awareness leading to im-
proved disease management. Because neither pollen nor
Figure 2. Selected time series, BCR, 2005–2011. Top: daily pollen concentrations of Alternaria, Betula and Poaceae, scaled (divided by the
maximum concentration observed for these three types). Middle: Daily number of boxes of eligible medications purchased by women, ages 19–
39 and 40–64 (excluding Saturdays, Sundays and holidays). Bottom: Daily number of boxes of eligible medications purchased by men, ages 40–
64 and 65–84 (excluding Saturdays, Sundays and holidays)
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fungal spore concentrations exhibited a strong increase
during the study period, it seems less likely that they con-
tributed to the increase in prevalence. Furthermore, no
substantial increase was detected in the decades before the
study period (Detandt and Nolard 2000) and the spread of
highly allergenic plants such as Ambrosia or Artemisia re-
mained rather limited in Belgium. In spite of its possible
impact on allergic rhinitis prevalence (D’Amato et al. 2001;
Hwang et al. 2006), air pollution is also unlikely to be
responsible for this disease prevalence increase. Indeed,
PM10, NO2 and O3 concentrations did not show substantial
variations between 2005 and 2011 and SO2 level even de-
creased.
The prevalence of treated allergic rhinitis varied across
demographic factors: while boys appeared more likely to
consume allergy medications during childhood, this trend
reversed after the puberty, women appearing more affected.
This observation may reveal true disparity in sensitization,
disease prevalence as already demonstrated (Osman et al.
2007; Govaere et al. 2007) or difference in disease percep-
tion and management. Indeed, previous studies have shown
that women were more likely to report psychosocial effects
due to allergic rhinitis and perceived it as a more threat-
ening disease, leading to a possible greater use of medica-
tions (Chen et al. 2008; Pesut et al. 2014).
Positive associations were observed between Poaceae,
Betula, Carpinus, Fraxinus, Quercus and medication sales.
Poaceae affected the widest age group and led to the highest
increase of relative risk per IQR (up to 1.13 CI 95% [1.11–
1.14] among 19- to 39-year-old men). This family has been
recognized as a major cause of pollinosis (D’Amato et al.
2007). In Belgium, it includes around 100 species, with
different allergenic potential, which consecutively pollinate
resulting in one of the longest pollination season. Betula
displayed the second most consistent relationship, followed
by Carpinus and Fraxinus. Betula is by far the most aller-
genic and common tree pollen in Belgium (Detandt and
Nolard 2000). It is widely used as ornamental tree and is
responsible for around one-third of the total tree pollen
load. Its maximal concentration was much higher than the
one recorded in France for instance (up to eight times
more) (Zeghnoun et al. 2005; Fuhrman et al. 2007).
Analogous works showed similar results (Ravault et al.
2005; Zeghnoun et al. 2005; Fuhrman et al. 2007; Sheffield
et al. 2011; Van Vliet and Tobi 2012; Caillaud et al. 2015).
Associations existed with Quercus but were inconsistent.
This may be explained by cross-allergenicity phenomenon:
Betula pollination which occurs just before may have
concentrated drug sales. This observation agrees with
Fuhrman’s and Caillaud’s results (Fuhrman et al. 2007;
Caillaud et al. 2015) but not with other French or American
studies (Ravault et al. 2005; Zeghnoun et al. 2005; Sheffield
et al. 2011; Motreff et al. 2013). Contrary to what has been
observed in France (Ravault et al. 2005; Zeghnoun et al.
2005; Motreff et al. 2013), Taxus Cupressaceae levels were
not significantly associated with medication sales. Cupres-
saceae trees are relatively rare in Belgium compared with
southern parts of Europe. Sensitivity to this pollen type
being conditioned to its abundance, Belgian patients may
be subjected to lower concentrations than in France and so
be less sensitized (Charpin et al. 1990). This is confirmed by
the GA2LEN study which highlighted a low sensitization
rate to this type in Belgium (Burbach et al. 2009).
Regarding Corylus and Alnus, despite their recognized
allergenic potential (Weryszko-Chmielewska et al. 2001;
D’Amato et al. 2007), no significant association with
medication sales was detected here. The relatively low levels
of exposure are unlikely to explain such result as daily
concentrations less than 50 grains/m3 are sufficient to
trigger first symptoms (Weryszko-Chmielewska et al. 2001;
Rapiejko et al. 2007). Moreover, Belgian patients do not
present a lower sensitivity to these allergens compared with
the European average or France where significant associa-
tions with medication sales were observed for concentra-
tions of the same order of magnitude (Ravault et al. 2005;
Zeghnoun et al. 2005; Fuhrman et al. 2007; Burbach et al.
2009). These pollen types being mainly released during the
winter/early spring, one could consider a misdiagnosis
between allergies and cold and so the consumption of
medications different from antihistamines.
Regarding Alternaria or Cladosporium spores, a con-
sistent significant negative association with medication
sales was observed. In the framework of the European
Community Respiratory Health Survey (ECRHS), Bous-
quet showed low sensitization to these allergens in the
Belgian population (less than 2.5%) (Bousquet et al. 2007).
Moreover, this result is likely to be related to Poaceae which
pollinates just before. The few patients sensitized to these
allergens may be already under treatment at the time fungal
spores peak. In a similar study carried out in Australia, no
significant association was observed between medication
sales and total fungal spores (Johnston et al. 2009).
It should be noted that patient susceptibility is likely to
vary throughout the year according to pollen, spore con-
centrations, air pollution levels but also due to physiolog-
ical reactions. Two panel studies investigated the
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correlation between Poaceae pollen concentrations and
symptoms developed by a sample of sensitized patients
(Nolard and Duchaine 1978; Weger et al. 2011). In both
cases, patients experienced more severe symptoms in the
early season compared to the late season at similar pollen
concentrations. These observations were not significantly
affected by medication use or co-sensitization to another
pollen. This reaction might be explained by a mechanism of
priming according to which repeated exposure to pollen
may induce tolerance.
When considering age, different profiles appeared. The
group 19–64 years was the most affected, responding to the
widest group of pollen and showing the highest relative
risks. Despite a rather high percentage of individuals buy-
ing at least one allergy drug, scarce significant relationships
were demonstrated for ages above 64 years. When looking
at specific time series for these age groups, it is clear that
seasonality is much less pronounced than in the younger
populations. Elderly individuals are likely to follow a sales
pattern different from the general population due to vari-
ations in healthcare use. Indeed, diagnosis is complicated
by concurrent diseases provoking similar symptoms and
treatment strategy may differ from the general population
to limit drug interactions (Busse and Kilaru 2009). In
addition, older persons might be less exposed to aeroal-
lergens due to mobility limitations. This absence of asso-
ciation is not always observed in similar works (Ravault
et al. 2005; Zeghnoun et al. 2005; Fuhrman et al. 2007;
Motreff et al. 2013; Caillaud et al. 2015).
Comparing the studies to each other, one must keep in
mind the use of different methodologies. Both the statis-
tical methods and disease characterization vary widely be-
tween studies. In New York, allergy medications sold Over
The Counter (OTC) were used (Sheffield et al. 2011). While
this strategy permitted to catch mild cases who do not seek
physician’s diagnosis, it also goes hand in hand with a loss
of specificity by the inclusion of people with a wrong self-
diagnosis or an influence of advertisements and promo-
tions. In the Netherlands, all purchases of an oral antihis-
tamine or a local anti-allergic drug were considered, as well
as other ATC groups (Van Vliet and Tobi 2012). Moreover,
data were aggregated to the weekly level in order to avoid
the discrepancy between weekdays and weekends. Such an
approach is valid, albeit costly in terms of precision. In
French studies, cases were defined as the combined pre-
scription of an oral antihistamine drug with a local anti-
allergic drug (Ravault et al. 2005; Zeghnoun et al. 2005;
Fuhrman et al. 2007; Motreff et al. 2013; Caillaud et al.
2015). For this study, allergic rhinitis cases were identified
by the use of at least one medication belonging to the ATC
category called ‘‘Antihistamines for systemic use’’. This
choice was, among others, supported by a study carried out
in Belgium showing that oral antihistamines were the most
frequently prescribed drugs (82.2% of patients received
such a treatment) (Van Hoecke et al. 2006). Attempts were
made to apply the French strategy on the Brussels case but
this reduces the number of cases by a factor of four or
more. Because the Poisson model is only valid if the daily
counts are sufficiently large, this would have necessitated
aggregating over age and gender groups, thus leading to less
homogeneous age groups. Therefore, this definition would
not have led to larger precision or power and information
in subpopulation sensitivity would have been lost. This
highlights the importance to consider the local context in
terms of medical practices, refund policy and in general-
izing/adapting the statistical methodology.
This is the first Belgian study investigating the short-
term effect of pollen grains and fungal spores on medica-
tion sales. The Belgium capital constituted a very interest-
ing field of study considering the high prevalence of allergic
rhinitis in this country. Data used here distinguished
themselves by their reliability and comprehensiveness. In-
deed, they relied on a systematic recording organized by the
national health insurance and concerned any Belgian resi-
dents. This system did not restrict to persons affiliated to a
specific insurance programme or to a subset of pharmacies
as for most of the previous works wherein population
coverage ranged from 30% to 80% (Ravault et al. 2005;
Sheffield et al. 2011). This present study also covered one of
the longest period (7 years), increasing the statistical power
of the analysis. Only one study investigated a longer time
interval (10 years) (Caillaud et al. 2015).
Nevertheless, some limitations common to all studies
analysing the relationship between aeroallergens and
medication sales must be underlined. First, sales of reim-
bursed allergy drugs remain a proxy of allergic rhinitis
morbidity due to pollen and fungal spores. Indeed, the
specificity and the sensitivity of ‘‘Antihistamines for sys-
temic use’’ medications to catch allergic rhinitis cases due
to pollen and spores are not perfect. These drugs are for
instance also included in many cough and cold prepara-
tions and can be used to treat urticarial skin rashes.
Moreover, non-antihistamines such as intranasal steroids
can also be prescribed for allergic rhinitis. More generally,
the use of allergy medications is not limited to pollen and
fungal spores: they can be prescribed for allergy to dust
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mite and pets’ dander. This issue is all the more significant
in Europe where a large portion of the population is sen-
sitized to these allergens (the median age–sex standardized
prevalence reaches 21.7% for Dermatophagoides
pteronyssinus and 8.8% for cat’s dander according to the
ECRHS (Bousquet et al. 2007)). These allergens contribute
to the non-zero background level observed in allergy
medication sales. Besides, sales of reimbursed drugs lead to
focus on people diagnosed and treated with reimbursed
medications. This is likely to exclude from the analysis
patients with mild symptoms who do not seek healthcare,
use alternative therapies. Also, misdiagnosis and so inade-
quate treatment is possible, especially late winter when
allergic rhinitis might be confounded with its infectious
equivalent or cold. Furthermore, sales are not necessarily
synonymous of symptoms. Indeed, they can correspond to
purchase in prevention which might be a common practice
among diagnosed people. Besides, one drug box may serve
for several exposure periods. This might lead to underes-
timate real pollen impact. Second, an approximation is
made regarding pollen and spore levels. Aeroallergen
counts do not consider variations in distribution across the
city, time spent outdoor by each person, etc. According to
previous works, they tend to imperfectly estimate personal
exposure but show a good correlation with patients’
symptomology (Riediker et al. 2000; Frenz 2001; O’Meara
et al. 2004; Brito et al. 2011). In this study, all individuals
lived within 10 km of the spore trap. Restriction of the
analysis to a smaller area did not show sensitivity. Third,
the statistical models currently available account for sea-
sonal trends and multiple confounders. However, as the
aeroallergens are introduced one at a time, they do not
consider cross-allergenicity phenomena, overlap in polli-
nation period. One could consider using multi pollen and
spore models to produce more accurate relative risk esti-
mates. However, large correlations between pollen con-
centrations exist (Spearman q > 0.7) and prevent the use
of such analyses. Furthermore, no satisfactory statistical
approach yet exists for the variety of synergies (interac-
tions) that may result from the complex interplay between
sequential exposures and administration of personal stock.
CONCLUSION
This work relied on large national datasets which provided
great information on allergic rhinitis management over a
lengthy period. It highlighted the crucial role of Poaceae, Be-
tula, Carpinus, Fraxinus and Quercus in allergic rhinitis mor-
bidity in the BCR. Risks varied according to age and gender:
the 19–64 years group was sensitive to the widest diversity of
pollen and showed the highest relative risk. On the field, these
conclusions could help to customize prevention programmes.
With this in mind, it could be interesting to go into subpop-
ulation sensitivity in depth considering for instance the impact
of concomitant asthma or socioeconomic status. These kind of
analyses could also be used in combination with clinical
studies to monitor disease prevalence or severity in response to
allergens and detect potential changes related to on-going
environmental alterations (Ambrosia, Artemisia propagation,
peak air pollution, etc.).
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